Navigation Links
EMD Serono, Inc. Named as a Top Employer by Science Magazine
Date:10/5/2009

ROCKLAND, Mass., Oct. 5 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that Science magazine has named it one of the world's leading biotechnology and pharmaceutical employers. EMD Serono's ranking improved to No. 6 this year, up from No. 7 in 2008 and No. 17 in 2007.

"This is a great honor because the survey by Science sought opinions from people within the scientific community, people who actually know the biotech and pharmaceutical industries very well," said Dr. Bernhard Kirschbaum, Executive Vice President, Research & Development, Merck Serono, an affiliate of Merck KGaA, Darmstadt, Germany. "This is a compliment to the dedication, skills and hard work of our employees. It's also a statement to the rest of the scientific community that EMD Serono is an employer that offers a great working environment, the chance for professional development and an opportunity to help mankind."

Science's 2009 Top Employers Survey queried 2,334 people. Participants came from North America (73%), Europe (15%) and the Pacific Rim (8%). Respondents were asked to write in the names of companies they considered best, average and worst employers. They then rated these companies on 23 different attributes.

Attribute categories included Corporate Image, Financial Prowess, Leadership and Direction, Work Culture/Environment, Location, and Academic and Intellectual Challenge.

EMD Serono won special recognition for having loyal employees, being socially responsible and doing important, quality research.

EMD Serono appears on the list as Merck KGaA, Darmstadt, Germany, of which it is an affiliate.

Science and the American Association for the Advancement of Science (AAAS) commissioned Cell Associated and The Brighton Consulting Group to conduct the survey to determine which employers in the biotech and pharmaceutical industries had the best reputations.

Email questionnaires were sent to AAAS members, Science Career registrants, Science website visitors registered with AAAS, and past survey takers, as well as human resources contacts from the Science Careers database.

About EMD Serono

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, with Rebif® (interferon beta-1a), as well as in endocrinology, with Saizen® (somatropin (rDNA origin) for injection) and Serostim® (somatropin (rDNA origin) for injection). EMD Serono is a leader in reproductive health, with Gonal-f® (follitropin alfa for injection), Luveris® (lutropin alfa for injection) and Ovidrel® Prefilled Syringe (choriogonadotropin alfa injection). With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono's US footprint continues to grow, with more than 1000 employees around the country and fully integrated commercial, clinical and research operations in the company's home state of Massachusetts.

For more information, please visit www.emdserono.com

About Merck KGaA

Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.6 billion in 2008, a history that began in 1668, and a future shaped by 32,700 employees in 60 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit www.merckserono.com or www.merck.de

SOURCE EMD Serono, Inc.


'/>"/>
SOURCE EMD Serono, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. American Board of Internal Medicine President Named to Alzheimers Study Group
3. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
4. Pharmaxis Establishes Named Patient Program for Bronchitol
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
7. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
8. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
9. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Calif. , April 29, 2016  In ... is projected to shift from systems dependent on ... all types of modality CRT Medical monitors and ... there are a host of foreseeable benefits to ... concern; will existing modalities have to be replaced ...
(Date:4/29/2016)... 2016 ReportsnReports.com adds "Pulmonary ... research report that provides an overview of the ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Pulmonary ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology:
(Date:4/29/2016)... Hills, CA (PRWEB) , ... April 29, 2016 , ... ... of devices and products for the head and neck/ear, nose and throat specialty, has ... Device , The KOTLER NASAL AIRWAY™ is a newly patented safety device ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... growth round of funding led by Eastside Partners, with participation from existing investor ... growing customer base and accelerate its technology and product roadmap. , ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 ... survey, earning them second place for Tampa’s Best Places to Work. They were ranked ... is a great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. recently sent representatives ... Petbiotics ™, as they fondly call them. As animal lovers, they were ... their non-profit organizations. Animal rescues across the nation face huge hurdles rescuing animals ...
Breaking Medicine News(10 mins):